Y. Hou et al. / Tetrahedron: Asymmetry xxx (2017) xxx–xxx
7
(d, J = 6.8 Hz, 1H), 4.12–4.09 (m, 3H), 3.78 (s, 3H), 3.74–3.62 (m,
4.4.14. (2R,3S,4R,5R)-3,4-Diethyl 2-methyl 5-
3H), 3.57–3.53 (m, 1H), 3.18 (br s, 1H), 1.22 (t, J = 7.2 Hz, 3H),
0.83 (t, J = 7.2 Hz, 3H); The ee value was 94%, tR (minor)
= 7.05 min, tR (major) = 11.05 min (Chiralcel AS-H, k = 230 nm, i-
PrOH/hexanes 50:50, flow rate = 0.8 mL/min).
cyclohexylpyrrolidine-2,3,4-tricarboxylate 8j
Yield: 38 mg (54%); [
a]
D
30 = ꢀ4.3 (c 0.95, CH2Cl2); 1H NMR
(400 MHz, CDCl3) d 4.25–4.17 (m, 1H), 4.13–4.06 (m, 3H), 4.02
(d, J = 10.0 Hz, 1H), 3.74 (s, 3H), 3.52 (dd, J = 10.0, 7.6 Hz, 1H),
3.18 (dd, J = 7.2, 4.8 Hz, 1H), 2.79 (dd, J = 10.0, 4.8 Hz, 1H), 2.73
(br, 1H), 2.06 (d, J = 12.8 Hz, 1H), 1.87 (d, J = 12.4 Hz, 1H), 1.73–
1.63(m, 3H), 1.41–1.32 (m, 1H), 1.25 (t, J = 7.2 Hz, 3H), 1.22 (t,
J = 7.2 Hz, 3H), 1.27–1.11 (m, 3H), 1.09–0.94 (m, 2H); The ee value
was 69%, tR (major) = 8.76 min, tR (minor) = 10.61 min (Chiralcel
AD-H, k = 210 nm, i-PrOH/hexanes 15:85, flow rate = 0.8 mL/min).
4.4.8. (2S,3R,4S,5R)-3,4-Diethyl 2-methyl 5-(4-fluorophenyl)-
pyrrolidine-2,3,4-tricarboxylate 8d
Yield: 61 mg (84%); [a]
30 = +48.6 (c 1.10, CH2Cl2); The ee value
D
was ꢀ95%, tR (minor) = 6.93 min, tR (major) = 10.94 min (Chiralcel
AS-H, k = 230 nm, i-PrOH/hexanes 50:50, flow rate = 0.8 mL/min).
4.4.9. (2R,3S,4R,5S)-3,4-Diethyl 2-methyl 5-(4-chlorophenyl)-
4.4.15. (2R,3S,4R,5R)-3,4-Diethyl 2-methyl 5-
pyrrolidine-2,3,4-tricarboxylate 8e
neopentylpyrrolidine-2,3,4-tricarboxylate 8k
Yield: 76 mg (99%); [
a
]
D
30 = ꢀ46.2 (c 0.92, CH2Cl2); 1H NMR
Yield: 32 mg (46%); [a]
30 = +2.6 (c 1.00, CH2Cl2); 1H NMR
D
(400 MHz, CDCl3) d 7.33–7.28 (m, 4H), 4.44 (d, J = 6.8 Hz, 1H),
4.16–4.10 (m, 3H), 3.80 (s, 3H), 3.76–3.68 (m, 3H), 3.60–3.56 (m,
1H), 3.27 (br s, 1H), 1.24 (t, J = 7.2 Hz, 3H), 0.87 (t, J = 7.2 Hz, 3H);
The ee value was 93%, tR (minor) = 7.41 min, tR (major)
= 12.17 min (Chiralcel AS-H, k = 230 nm, i-PrOH/hexanes 50:50,
flow rate = 0.8 mL/min).
(400 MHz, CDCl3) d 4.14 (q, J = 6.0 Hz, 2H), 4.08 (q, J = 6.0 Hz, 2H),
3.98 (d, J = 7.2 Hz, 1H), 3.73 (s, 3H), 3.53–3.50 (m, 1H), 3.19–3.16
(m, 1H), 3.12–3.10 (m, 1H), 2.61 (br, 1H), 1.52 (dd, J = 11.2,
3.2 Hz, 1H), 1.39 (dd, J = 11.2, 6.0 Hz, 1H), 1.25 (t, J = 6.0 Hz, 3H),
1.22 (t, J = 6.0 Hz, 3H), 0.94 (s, 9H); 13C NMR (100 MHz, CDCl3) d
171.4, 171.2, 170.1, 61.8, 60.9, 60.4, 59.5, 52.1, 52.1, 44.2, 30.3,
29.9, 14.2, 14.0; HRMS (ESI): calcd for
C
17H29N1O6 [M+H]+
4.4.10. (2R,3S,4R,5S)-3,4-Diethyl 2-methyl 5-(naphthalen-2-yl)
pyrrolidine-2,3,4-tricarboxylate 8f
344.2068, found 344.2063; The ee value was 64%, tR (major)
= 7.96 min, tR (minor) = 8.62 min (Chiralcel AD-H, k = 210 nm, i-
PrOH/hexanes 15:85, flow rate = 0.7 mL/min).
Yield: 70 mg (88%); [
a
]
D
30 = ꢀ32.4 (c 1.10, CH2Cl2); 1H NMR
(400 MHz, CDCl3) d 7.83–7.78 (m, 4H), 7.47–7.44 (m, 3H), 4.61
(dd, J = 6.4, 2.4 Hz, 1H), 4.13 (q, J = 7.2 Hz, 2H), 3.83 (s, 3H), 3.79–
3.75 (m, 1H), 3.71–3.53 (m, 3H), 3.42 (br s, 1H), 1.24 (t,
J = 7.2 Hz, 3H), 0.67 (t, J = 7.2 Hz, 3H); The ee value was 94%, tR
(minor) = 7.69 min, tR (major) = 21.51 min (Chiralcel AS-H,
k = 230 nm, i-PrOH/hexanes 50:50, flow rate = 0.8 mL/min).
4.4.16. (2R,3S,4R,5S)-3,4-Diethyl 2-methyl 2-methyl-5-
phenylpyrrolidine-2,3,4-tricarboxylate 8l
Yield: 65 mg (90%); [
a
]
30 = ꢀ41.2 (c 1.25, CH2Cl2); 1H NMR
D
(400 MHz, CDCl3) d 7.37–7.24 (m, 5H), 4.63 (d, J = 6.4 Hz, 1H),
4.20 (q, J = 7.2 Hz, 2H), 3.79 (s, 3H), 3.78–3.65 (m, 2H), 3.47 (t,
J = 7.2 Hz, 1H), 3.28 (d, J = 6.8 Hz, 1H), 1.68 (s, 3H), 1.29 (t,
J = 7.2 Hz, 3H), 0.80 (t, J = 7.2 Hz, 3H); The ee value was 93%, tR
(major) = 7.49 min, tR (minor) = 12.88 min (Chiralcel AD-H,
k = 210 nm, i-PrOH/hexanes 15:85, flow rate = 0.8 mL/min).
4.4.11. (2R,3S,4R,5S)-3,4-Diethyl 2-methyl 5-(furan-2-yl)
pyrrolidine-2,3,4-tricarboxylate 8g
Yield: 60 mg (88%); [
a]
30 = ꢀ36.8 (c 1.43, CH2Cl2); 1H NMR
D
(400 MHz, CDCl3) d 7.33–7.32 (m, 1H), 6.33–6.31 (m, 2H), 4.47
(d, J = 6.8 Hz, 1H), 4.12 (q, J = 7.2 Hz, 2H), 4.22 (d, J = 8.8 Hz, 1H),
3.94–3.85 (m, 2H), 3.78 (s, 3H), 3.62 (dd, J = 8.0, 8.8 Hz, 1H), 3.50
(t, J = 7.6 Hz, 1H), 3.24 (br s, 1H), 1.23 (t, J = 7.2 Hz, 3H), 1.03 (t,
J = 7.2 Hz, 3H); The ee value was 95%, tR (minor) = 7.16 min, tR
(major) = 16.40 min (Chiralcel AS-H, k = 230 nm, i-PrOH/hexanes
50:50, flow rate = 0.8 mL/min).
4.4.17. (2R,3S,4R,5S)-3,4-Diethyl 2-methyl 2-methyl-5-(p-tolyl)
pyrrolidine-2,3,4-tricarboxylate 8m
Yield: 67 mg (84%); [
a]
30 = ꢀ26.9 (c 0.75, CH2Cl2); 1H NMR
D
(400 MHz, CDCl3) d 7.22 (d, J = 8.0 Hz, 2H), 7.08 (d, J = 7.6 Hz, 2H),
4.56 (d, J = 6.4 Hz, 1H), 4.17 (q, J = 7.2 Hz, 2H), 3.77 (s, 3H), 3.77–
3.66 (m, 3H), 3.43 (t, J = 6.8 Hz, 1H), 3.25 (d, J = 6.8 Hz, 1H), 2.29
(s, 3H), 1.65 (s, 3H), 1.28 (t, J = 7.2 Hz, 3H), 0.81 (t, J = 7.2 Hz, 3H);
The ee value was 93%, tR (major) = 7.46 min, tR (minor)
= 10.48 min (Chiralcel AD-H, k = 210 nm, i-PrOH/hexanes 15:85,
flow rate = 0.8 mL/min).
4.4.12. (2R,3S,4R,5S)-3,4-Diethyl 2-methyl 5-(thiophen-2-yl)
pyrrolidine-2,3,4-tricarboxylate 8h
Yield: 67 mg (94%); [
a]
30 = ꢀ40.2 (c 1.20, CH2Cl2); 1H NMR
D
(400 MHz, CDCl3) d 7.19 (d, J = 4.8 Hz, 1H), 7.02–7.01 (m, 1H),
6.94–6.92 (m, 1H), 4.59 (d, J = 6.8 Hz, 1H), 4.13–4.10 (m, 3H),
3.86–3.82 (m, 2H), 3.77 (s, 3H), 3.67 (dd, J = 9.2, 8.0 Hz, 1H), 3.67
(dd, J = 8.0, 6.8 Hz, 1H), 3.34 (br s, 1H), 1.23 (t, J = 7.2 Hz, 3H),
0.96 (t, J = 7.2 Hz, 3H); The ee value was 92%, tR (minor)
= 7.65 min, tR (major) = 17.53 min (Chiralcel AS-H, k = 230 nm, i-
PrOH/hexanes 50:50, flow rate = 0.8 mL/min).
4.4.18. (2R,3S,4R,5S)-3,4-Diethyl 2-methyl 5-(4-fluorophenyl)-2-
methylpyrrolidine-2,3,4-tricarboxylate 8n
Yield: 59 mg (78%); [
a]
D
30 = ꢀ34.6 (c 1.34, CH2Cl2); 1H NMR
(400 MHz, CDCl3) d 7.35–7.32 (m, 2H), 7.00–6.96 (m, 2H), 4.59
(d, J = 6.4 Hz, 1H), 4.17 (q, J = 7.2 Hz, 2H), 3.77 (s, 3H), 3.69–3.66
(m, 2H), 3.58 (br s, 1H), 3.44 (t, J = 7.2 Hz, 1H), 3.25 (d, J = 7.2 Hz,
1H), 1.64 (s, 3H), 1.27 (t, J = 7.2 Hz, 3H), 0.82 (t, J = 7.2 Hz, 3H);
The ee value was 96%, tR (major) = 8.56 min, tR (minor)
= 13.13 min (Chiralcel AD-H, k = 210 nm, i-PrOH/hexanes 15:85,
flow rate = 0.8 mL/min).
4.4.13. (2R,3S,4R,5S)-3,4-Diethyl 2-methyl 5-(pyridine-3-yl)
pyrrolidine-2,3,4-tricarboxylate 8i
Yield: 51 mg (73%); Mp. 102–105 °C; [
a]
D
30 = ꢀ48.5. (c 0.84, CH2-
Cl2); 1H NMR (400 MHz, CDCl3) d 8.60–8.52 (m, 2H), 7.79 (d,
J = 7.2 Hz, 1H), 7.29–7.26 (m, 1H), 4.51 (d, J = 6.4 Hz, 1H), 4.17–
4.12 (m, 3H), 3.81 (s, 3H), 3.78–3.63 (m, 4H), 3.37 (br, 1H), 1.25
(t, J = 7.2 Hz, 3H), 0.84 (t, J = 7.2 Hz, 3H); 13C NMR (100 MHz, CDCl3)
d 170.7, 170.2, 170.0, 149.0, 148.9, 134.3, 133.1, 123.2, 62.8, 62.2,
61.2, 60.6, 52.4, 52.3, 50.9, 14.0, 13.6; The ee value was 98%, tR
(minor) = 9.06 min, tR (major) = 10.59 min (Chiralcel AS-H,
k = 230 nm, i-PrOH/hexanes 50:50, flow rate = 0.8 mL/min).
4.4.19. (2R,3S,4R,5S)-3,4-Diethyl 2-methyl 5-(4-bromophenyl)-
2-methylpyrrolidine-2,3,4-tricarboxylate 8o
Yield: 73 mg (83%) [
a
]
30 = ꢀ25.6 (c 1.40, CH2Cl2). 1H NMR
D
(400 MHz, CDCl3) d 7.37 (d, J = 8.3 Hz, 2H), 7.19 (d, J = 8.1 Hz, 2H),
4.51 (d, J = 6.6 Hz, 1H), 4.12 (q, J = 7.1 Hz, 1H), 3.71 (s, 3H), 3.79–
3.46 (m, 3H), 3.39 (t, J = 6.9 Hz, 1H), 3.19 (d, J = 7.1 Hz, 1H), 1.59
(s, 3H), 1.22 (t, J = 7.1 Hz, 3H), 0.79 (t, J = 7.1 Hz, 3H); 13C NMR
(100 MHz, CDCl3): 174.3, 170.5, 170.3, 136.7, 131.3, 128.8, 121.5,